(Q44349674)

2 December 2017

Pain tolerance in opioid addicts on and off naltrexone pharmacotherapy: a pilot study (English)

1 reference

2 December 2017

0 references

0 references

Compton P

1

1 reference

2 December 2017

1 July 1998

1 reference

Journal of Pain and Symptom Management

2 December 2017

1 reference

2 December 2017

16

1 reference

2 December 2017

1

1 reference

2 December 2017

21-28

1 reference

Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Strategies to Improve Compliance with Narcotic Antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Experience of a "slip" among alcoholics treated with naltrexone or placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Naltrexone in the treatment of alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Naltrexone in autistic children: an acute open dose range tolerance trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Beta-endorphin disregulation in autistic and self-injurious behavior: a neurodevelopmental hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

The use of opiate antagonists for recurrent self-injurious behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Naltrexone treatment of self-injurious thoughts and behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Naltrexone in treatment of self injurious behavior: a clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Effect of a tricyclic antidepressant and opiate antagonist on binge-eating behavior in normoweight bulimic and obese, binge-eating subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Naltrexone and bulimic symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Naltrexone reverses bulimic symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Treatment of antidepressant-resistant bulimia with naltrexone

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

The use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexone

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

A review of the controlled trials of pharmacotherapy and psychotherapy in the treatment of bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Effects of long-term therapy with naltrexone on body weight in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Naltrexone and human eating behavior: a dose-ranging inpatient trial in moderately obese men.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

High-dose naltrexone therapy and dietary counseling for obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Effect of naltrexone on food intake, hunger, and satiety in obese men.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Lack of effect of naloxone on pain perception in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Effects of naloxone on experimentally induced ischemic pain and on mood in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Endorphins: Naloxone Fails to Alter Experimental Pain or Mood in Humans

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Naloxone decreases diurnal variation in pain sensitivity and somatosensory evoked potentials

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Naloxone enhancement of acetic acid-induced writhing in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Intracerebroventricular naloxone produces a dose-dependent, monotonic increase in nociceptive threshold in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Low doses of naloxone produce analgesia in the mouse brain by blocking presynaptic autoinhibition of enkephalin release

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Naloxone-sensitive, pregnancy-induced changes in behavioral responses to colorectal distention: pregnancy-induced analgesia to visceral stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Analgesia produced by low doses of the opiate antagonist naloxone in arthritic rats is reduced in morphine-tolerant animals.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Dose-dependent analgesic and hyperalgesic effects of systemic naloxone in arthritic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Cross-tolerance between analgesic low doses of morphine and naloxone in arthritic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

The narcotic antagonist naloxone enhances clinical pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Method of administration determines the effect of naloxone on pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Placebo and naloxone can alter post-surgical pain by separate mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Potentiation of pentazocine analgesia by low-dose naloxone

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Objective assessment of clonidine analgesia in man and influence of naloxone

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Met-enkephalin levels and opiate receptors in the spinal cord of chronic suffering rats

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Afferent fibers mediate the increase of met-enkephalin elicited in rat spinal cord by localized pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Prodynorphin gene expression is enhanced in the spinal cord of chronic arthritic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

"Paradoxical" analgesia induced by naloxone and naltrexone

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Naloxone-induced analgesia: effects of the benzodiazepine antagonist Ro 15-1788.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Effect of naloxone on the habituation of novelty-induced hypoalgesia: the collateral inhibition hypothesis revisited.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Chronic selective blockade of mu opioid receptors produces analgesia and augmentation of the effects of a kappa agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

NALOXONE REVERSAL OF ISCHAEMIC NEUROLOGICAL DEFICITS IN MAN

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

The use of the opiate antagonist, naloxone, in the treatment of intractable pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

A double-blind trial of naloxone in central post-stroke pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Modification of the response to opioid and monopioid drugs by chronic opioid antagonist treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Chronic naltrexone supersensitizes the reinforcing and locomotor-activating effects of morphine.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Phasic pains induced by cold

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Naltrexone: disposition, metabolism, and effects after acute and chronic dosing

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Normative model for cold pressor test.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Cold-pressor pain tolerance in opiate and cocaine abusers: correlates of drug type and use status

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Opiate receptor binding--enhancement by opiate administration in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Long-term exposure to opioid antagonists up-regulates prodynorphin gene expression in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

beta-Endorphin-like immunoreactivity in plasma, pituitaries and hypothalamus of rats following treatment with opiates.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Effect of endocrine modifications and pharmacological treatments on brain and pituitary concentrations of beta-endorphin

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Effect of Chronic Naltrexone and Methadone Administration on Brain Immunoreactive β-Endorphin in the Rat

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Impaired supersensitivity to morphine following chronic naltrexone treatment in senescent rats

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Simultaneous quantitation of norepinephrine, dopamine and serotonin in brain during and following chronic naltrexone administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Alcohol, customary drinking behavior, and pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

A dose-response study of the effects of alcohol on the perceptions of pain and discomfort due to electric shock in men at high familial-genetic risk for alcoholism

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Naloxone alters pain perception and somatosensory evoked potentials in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Reversal by naloxone of adaptation of rats to noxious stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Systemic administration of naloxone produces analgesia in BALB/c mice in the formalin pain test

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

Activation and expression of endogenous pain control mechanisms in rats given repeated nociceptive tests under the influence of naloxone.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2898%2900035-9

7 January 2021

10.1016/S0885-3924(98)00035-9

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

9707654